Latest News and Updates | Cantargia

* (R) = Regulatory press releases

May 15, 2020

(R) Cantargia presents new preclinical data on CAN04 in combination with chemotherapy at the 2020 AACR Annual Meeting

May 4, 2020

(R) Cantargia IND application for CAN04 approved by FDA

Apr 28, 2020

(R) Notice of annual general meeting in Cantargia AB (publ)

Apr 7, 2020

(R) Cantargia submits IND application for CAN04

Apr 7, 2020

(R) Cantargia provides update on development projects CAN04 and CAN10

Mar 31, 2020

(R) New number of shares and votes in Cantargia

Mar 20, 2020

(R) Prospectus relating to the listing of shares in Cantargia published

Mar 16, 2020

(R) Extraordinary general meeting in Cantargia AB (publ)

Mar 10, 2020

(R) Cantargia acquires Cellerant IP on IL1RAP

Feb 28, 2020

(R) New number of shares and votes in Cantargia

<< Newer press releases Older press releases >>

Interview with CEO Hilde H. Steineger - 2025-10-24

Redeye

Interview with CEO Hilde H. Steineger - 2025-10-07

BioStock

Interview with CSO David Liberg about new nadunolimab data in pancreatic cancer presented at AACR Pancreas Conference (In Swedish) - 2025-10-01

Redeye

Interview with Damian Marron about Otsuka Pharmaceutical's acquisition of CAN10 - 2025-07-17

BioStock

Interview with Damian Marron regarding the acquisition of CAN10 IL1RAP immunology program by Otsuka Pharmaceutical - 2025-07-15

Redeye

Cantargia Q1 2025 interview with Interim CEO Damian Marron - 2025-05-14

Redeye

Redeye interviews Interim CEO Damian Marron - 2025-02-07

Redeye